Medios AG

XETRA ILM1.DE

Medios AG Cash and Short-Term Investments for the year ending December 31, 2023: USD 78.41 M

Medios AG Cash and Short-Term Investments is USD 78.41 M for the year ending December 31, 2023, a -7.48% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Medios AG Cash and Short-Term Investments for the year ending December 31, 2022 was USD 84.75 M, a -55.80% change year over year.
Medios AG Cash and Short-Term Investments for the year ending December 31, 2021 was USD 191.73 M, a 693.19% change year over year.
Medios AG Cash and Short-Term Investments for the year ending December 31, 2020 was USD 24.17 M, a 37.88% change year over year.
Medios AG Cash and Short-Term Investments for the year ending December 31, 2019 was USD 17.53 M, a 30.12% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

XETRA: ILM1.DE

Medios AG

CEO	Mr. Matthias Gaertner
IPO Date	Dec. 28, 2007
Location	Germany
Headquarters	Heidestrasse 9
Employees	1,011
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Eyewear Pharmaceuticals

Description

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Key trends

Past 5 years